Chandramouli C, Tay WT, Bamadhaj NS, Tromp J, Teng TK, Yap JJL, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLOS Med. 2019;16:e1002916.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861–7.

Article  CAS  PubMed  Google Scholar 

Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults (vol 293, pg 1868, 2005). JAMA. 2005;294:182–182.

Google Scholar 

Bazzano LA, Gu DF, Whelton MR, Wu XQ, Chen CS, Duan XF, et al. Body mass index and risk of stroke among Chinese men and women. Ann Neurol. 2010;67:11–20.

Article  PubMed  PubMed Central  Google Scholar 

Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121:230–6.

Article  PubMed  Google Scholar 

Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med. 2007;167:1420–7.

Article  PubMed  Google Scholar 

Towfighi A, Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke. 2009;40:2704–8.

Article  PubMed  Google Scholar 

Funada S, Shimazu T, Kakizaki M, Kuriyama S, Sato Y, Matsuda-Ohmori K, et al. Body mass index and cardiovascular disease mortality in Japan: the Ohsaki Study. Prev Med. 2008;47:66–70.

Article  PubMed  Google Scholar 

Crisp AH, Mcguiness B. Jolly fat – Relation between obesity and psychoneurosis in general population. Br Med J. 1976;1:7–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61.

Article  PubMed  Google Scholar 

Lee EY, Lee YH, Yi SW, Shin SA, Yi JJ. BMI and all-cause mortality in normoglycemia, impaired fasting glucose, newly diagnosed diabetes, and prevalent diabetes: a cohort study. Diabetes Care. 2017;40:1026–33.

Article  PubMed  Google Scholar 

Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J. 2013;34:268–77.

Article  PubMed  Google Scholar 

Andersen KK, Olsen TS. The obesity paradox in stroke: Lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. 2015;10:99–104.

Article  PubMed  Google Scholar 

Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW. Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology. 2011;76:567–73.

Article  CAS  PubMed  Google Scholar 

World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications, Sydney Australia, 2000.

Adams HP Jr, Biller J. Classification of subtypes of ischemic stroke: History of the trial of org 10172 in acute stroke treatment classification. Stroke. 2015;46:e114–e117.

Article  PubMed  Google Scholar 

Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25:2220–6.

Article  CAS  PubMed  Google Scholar 

Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35.

Article  CAS  PubMed  Google Scholar 

Li Z, Zhou T, Li Y, Chen P, Chen L. Anemia increases the mortality risk in patients with stroke: a meta-analysis of cohort studies. Sci Rep. 2016;6:26636.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.

Article  PubMed  Google Scholar 

Jung JM, Kwon DY, Han C, Jo I, Jo SA, Park MH. Increased carotid intima-media thickness and plasma homocysteine levels predict cardiovascular and all-cause death: a population-based cohort study. Eur Neurol. 2013;70:1–5.

Article  CAS  PubMed  Google Scholar 

Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K. Chronic kidney disease and cerebrovascular disease: consensus and guidance From a KDIGO controversies conference. Stroke. 2021;52:e328–e346.

Article  CAS  PubMed  Google Scholar 

Blanc B: nutritional anemias. Report of a WHO Scientific Group [WHO Tech Rep. Ser.]. 405. 1968. pp 1–40.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. The ACCP/SCCM Consensus Conference Committee. 1992;101:1644–55.

CAS  Google Scholar 

Kim J, Park MH, Kim E, Han C, Jo SA, Jo I. Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J Nutr. 2007;137:2093–7.

Article  CAS  PubMed  Google Scholar 

van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219–42.

Article  PubMed  Google Scholar 

Rosenbaum PR, Rubin DB. Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–38.

Google Scholar 

Pirson FAV, Hinsenveld WH, Staals J, de Greef BTA, van Zwam WH, Dippel DWJ, et al. The effect of body mass index on outcome after endovascular treatment in acute ischemic stroke patients: a post hoc analysis of the mr clean trial. Cerebrovasc Dis. 2019;48:200–6.

Article  PubMed  Google Scholar 

Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.

Article  PubMed  Google Scholar 

Burke DT, Al-Adawi S, Bell RB, Easley K, Chen S, Burke DP. Effect of body mass index on stroke rehabilitation. Arch Phys Med Rehabil. 2014;95:1055–9.

Article  PubMed  Google Scholar 

Zhao L, Du W, Zhao X, Liu L, Wang C, Wang Y, et al. Favorable functional recovery in overweight ischemic stroke survivors: Findings from the China National Stroke Registry. J Stroke Cerebrovasc Dis. 2014;23:e201–206.

Article  PubMed  Google Scholar 

Kim Y, Kim CK, Jung S, Yoon BW, Lee SH. Obesity-stroke paradox and initial neurological severity. J Neurol Neurosurg Psychiatry. 2015;86:743–7.

Article  PubMed  Google Scholar 

Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.

Article  PubMed  Google Scholar 

Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E, et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–40.

Article  PubMed  Google Scholar 

Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, et al. Underweight is a risk factor for atrial fibrillation: A nationwide population-based study. Int J Cardiol. 2016;215:449–56.

Article  PubMed  Google Scholar 

Boriani G, Ruff CT, Kuder JF, Shi MG, Lanz HJ, Rutman H, et al. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019;40:1541–50. +

Article  CAS  PubMed  Google Scholar 

Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, et al. The ‘obesity paradox’ in atrial fibrillation: observations from the Aristotle (apixaban for Reduction in Stroke and Other thromboembolic Events in atrial fibrillation) trial. Eur Heart J. 2016;37:2869–78.

Article  PubMed  Google Scholar 

Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W. Stroke induced sarcopenia: muscle wasting and disability after stroke. Int J Cardiol. 2013;170:89–94.

Article  PubMed  Google Scholar 

Ohyama K, Watanabe M, Nosaki Y, Hara T, Iwai K, Mokuno K, et al. Correlation between skeletal muscle mass deficit and poor functional outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29:104623.

Article  PubMed  Google Scholar 

DeLany J. Leptin hormone and other biochemical influences on systemic inflammation. J Bodyw Mov Ther. 2008;12:121–32.

Article  PubMed  Google Scholar 

Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.